Roper Technologies
ROP Nasdaq Electronic Equipment & Instruments Financials FY2016βFY2025
Roper Technologies' revenue rose 12.3% to $7.9 billion in fiscal 2025. Its operating margin was 28.3%, down from 28.4% a year earlier. Free cash flow was $2.5 billion, up 7.1%. It paid out $855 million in dividends and buybacks, 34% of free cash flow. The diluted share count rose 0.2%.
What Roper Technologies does
No business description yet.
- Legal name
- ROPER TECHNOLOGIES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000882835-26-000009
0000882835
Revenue and margins
Roper Technologies had $7.9B of revenue in fiscal 2025, up 12.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.5B in fiscal 2025, 31.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Roper Technologies returned $855M to shareholders in fiscal 2025, 34% of free cash flow. The diluted share count rose 0.2%.
Value Roper Technologies yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$9.0B and divides by 108.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 18.1x Β· peers 32.0x Β· sector 33.5x.
Balance sheet
Cash, debt and the ratios that show how comfortably Roper Technologies can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $352M | $793M | $214M | $188M | $297M |
| Debt incl. finance leases | $7.9B | $6.7B | $6.3B | $7.6B | $9.3B |
| Net debt / EBITDA | 4.1x | 2.7x | 2.5x | 2.7x | 2.9x |
| Debt / equity | 0.7x | 0.4x | 0.4x | 0.4x | 0.5x |
| Interest coverage | 5.3x | 7.9x | 10.6x | 7.7x | 6.9x |
| Current ratio | 0.8x | 0.7x | 0.5x | 0.4x | 0.5x |
| Quick ratio | 0.8x | 0.6x | 0.5x | 0.4x | 0.5x |
| Total assets | $23.7B | $27.0B | $28.2B | $31.3B | $34.6B |
| Total liabilities | $12.2B | $10.9B | $10.7B | $12.5B | $14.7B |
| Shareholders' equity | $11.6B | $16.0B | $17.4B | $18.9B | $19.9B |
| Net debt (β = net cash) | $7.6B | $5.9B | $6.1B | $7.4B | $9.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$5.6M
3 insiders
Sold, 12 months
$19.1M
4 insiders
Of sales under plans
70%
$13.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | John K StipancichEVP, Chief Legal Officer & Sec | Sold | 2,000 | $379.05 | $0.8M | Form 4 |
| Jul 24, 2026 | Richard F WallmanDirector | Sold | 6,434 | $361.00 | $2.3M | Form 4 |
| Feb 6, 2026 | Thomas Patrick Joyce JRDirector | Bought | 1,400 | $358.46 | $0.5M | Form 4 |
| Dec 1, 2025 | Jason ConleyEVP, Chief Financial Officer | Sold | 6,000 | $445.57 | $2.7M | Form 4 |
| Nov 12, 2025 | Amy Woods BrinkleyDirector | Bought | 1,200 | $450.71 | $0.5M | Form 4 |
| Nov 12, 2025 | Laurence Neil HunnPresident and CEO, Director | Bought | 10,000 | $452.24 | $4.5M | Form 4 |
| Nov 11, 2025 | Laurence Neil HunnPresident and CEO, Director | Sold plan | 30,000 | $443.57 | $13.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 5 / 9 | 5 / 9 |
| Accruals ratio | β2.4% | β2.8% | β3.1% |
| Altman Z'' | 3.49 | 3.21 | 3.14 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Roper Technologies ROP | $44.1B | 12.3% | 28.3% | 31.6% | 6.4% | 18.2x | 5 | |
| Teledyne Technologies TDY | $29.3B | 7.9% | 18.8% | 17.6% | 7.8% | 28.6x | 7 | Compare β |
| Zebra Technologies ZBRA | $18.6B | 8.3% | 13.0% | 15.4% | 9.7% | 35.3x | 4 | Compare β |
| Keysight Technologies KEYS | $54.5B | 8.0% | 16.3% | 23.8% | 12.1% | 43.1x | 6 | Compare β |
| Vontier VNT | $4.8B | 3.2% | 18.3% | 14.3% | 15.8% | 14.2x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.8B | $4.6B | $5.2B | $4.7B | $4.0B | $4.8B | $5.4B | $6.2B | $7.0B | $7.9B |
| Gross profit | $2.3B | $2.9B | $3.3B | $3.1B | $2.8B | $3.4B | $3.8B | $4.3B | $4.9B | $5.5B |
| Research and development | $195M | $281M | $377M | $380M | $382M | $485M | $530M | $646M | $748M | $853M |
| Operating income | $1.1B | $1.2B | $1.4B | $1.3B | $1.1B | $1.2B | $1.5B | $1.7B | $2.0B | $2.2B |
| Interest expense | $112M | $181M | $182M | $186M | $219M | $234M | $192M | $165M | $259M | $325M |
| Pretax income | $941M | $1.0B | $1.2B | $2.1B | $861M | $1.0B | $1.3B | $1.7B | $2.0B | $1.9B |
| Income tax | $282M | $62.9M | $254M | $417M | $188M | $227M | $296M | $375M | $418M | $400M |
| Net income | $659M | $972M | $944M | $1.8B | $950M | $1.2B | $4.5B | $1.4B | $1.5B | $1.5B |
| Diluted EPS | $6.43 | $9.39 | $9.05 | $16.82 | $8.98 | $10.82 | $42.55 | $12.89 | $14.35 | $14.20 |
| Diluted shares | 0.10B | 0.10B | 0.10B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B |
| Cash flow | ||||||||||
| Cash from operations | $964M | $1.2B | $1.4B | $1.5B | $1.5B | $2.0B | $735M | $2.0B | $2.4B | $2.5B |
| Capital expenditure | $37.3M | $48.8M | $49.1M | $43.0M | $24.7M | $28.5M | $40.1M | $68.0M | $66.0M | $47.4M |
| Free cash flow | $927M | $1.2B | $1.4B | $1.4B | $1.5B | $2.0B | $695M | $2.0B | $2.3B | $2.5B |
| Depreciation and amortization | $241M | $345M | $367M | $409M | $492M | $616M | $650M | $755M | $813M | $898M |
| Stock-based compensation | $78.8M | $83.1M | $134M | $101M | $108M | $123M | $119M | $124M | $146M | $166M |
| Acquisitions | $3.7B | $154M | $1.3B | $2.4B | $6.0B | $217M | $4.3B | $2.1B | $3.6B | $3.3B |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $500M |
| Dividends paid | $121M | $143M | $170M | $192M | $214M | $236M | $262M | $290M | $322M | $355M |
| Dividends and buybacks | $121M | $143M | $170M | $192M | $214M | $236M | $262M | $290M | $322M | $855M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $757M | $671M | $364M | $710M | $308M | $352M | $793M | $214M | $188M | $297M |
| Total debt | $6.2B | $5.2B | $4.9B | $5.3B | $9.6B | $7.9B | $6.7B | $6.3B | $7.6B | $9.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $1.8B | $1.8B | $1.6B | $2.0B | $1.8B | $2.4B | $1.9B | $1.5B | $1.5B | $1.9B |
| Current liabilities | $1.4B | $2.0B | $1.4B | $2.4B | $2.4B | $3.1B | $2.9B | $3.0B | $3.8B | $3.7B |
| Inventory | $182M | $205M | $191M | $199M | $165M | $69.2M | $111M | $119M | $121M | $142M |
| Property and equipment, net | $141M | $143M | $129M | $140M | $127M | $82.7M | $85.3M | $120M | $150M | $157M |
| Total assets | $14.3B | $14.3B | $15.2B | $18.1B | $24.0B | $23.7B | $27.0B | $28.2B | $31.3B | $34.6B |
| Total liabilities | $8.5B | $7.5B | $7.5B | $8.6B | $13.5B | $12.2B | $10.9B | $10.7B | $12.5B | $14.7B |
| Shareholders' equity | $5.8B | $6.9B | $7.7B | $9.5B | $10.5B | $11.6B | $16.0B | $17.4B | $18.9B | $19.9B |
| Margins | ||||||||||
| Gross margin | 61.5% | 62.2% | 63.2% | 66.4% | 70.3% | 70.5% | 69.9% | 69.7% | 69.3% | 69.2% |
| Operating margin | 27.8% | 26.3% | 26.9% | 28.1% | 26.9% | 25.7% | 28.4% | 28.3% | 28.4% | 28.3% |
| EBITDA margin | 34.2% | 33.8% | 34.0% | 36.7% | 39.1% | 38.4% | 40.5% | 40.5% | 39.9% | 39.7% |
| Net margin | 17.4% | 21.1% | 18.2% | 37.4% | 23.6% | 23.8% | 84.6% | 22.4% | 22.0% | 19.4% |
| FCF margin | 24.5% | 25.7% | 26.6% | 30.0% | 37.3% | 41.0% | 12.9% | 31.8% | 33.1% | 31.6% |
| Returns | ||||||||||
| Return on capital | 7.8% | 10.1% | 9.3% | 8.0% | 5.0% | 5.0% | 5.7% | 6.0% | 6.3% | 6.4% |
| Return on capital employed | 9.5% | 9.6% | 10.7% | 9.0% | 5.8% | 5.9% | 6.8% | 7.1% | 7.6% | 7.7% |
| Return on equity | 11.9% | 15.4% | 12.9% | 20.5% | 9.5% | 10.5% | 32.9% | 8.3% | 8.5% | 7.9% |
| Return on assets | 5.4% | 6.8% | 6.4% | 10.6% | 4.5% | 4.8% | 17.9% | 5.0% | 5.2% | 4.7% |
| Growth | ||||||||||
| Revenue growth | 5.8% | 21.6% | 12.7% | β8.9% | β14.9% | 20.2% | 11.1% | 15.0% | 13.9% | 12.3% |
| Net income growth | β5.4% | 47.6% | β2.8% | 87.2% | β46.3% | 21.4% | 294.3% | β69.5% | 11.9% | β0.8% |
| EPS growth | β6.1% | 46.0% | β3.6% | 85.9% | β46.6% | 20.5% | 293.3% | β69.7% | 11.3% | β1.1% |
| FCF growth | 3.8% | 28.0% | 16.5% | 2.7% | 5.8% | 32.2% | β65.0% | 183.2% | 18.3% | 7.1% |
| Share count change | 0.9% | 1.0% | 0.9% | 0.7% | 0.6% | 0.8% | 0.3% | 0.6% | 0.6% | 0.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.2x | 2.9x | 2.6x | 2.6x | 5.9x | 4.1x | 2.7x | 2.5x | 2.7x | 2.9x |
| Debt / equity | 1.1x | 0.8x | 0.6x | 0.6x | 0.9x | 0.7x | 0.4x | 0.4x | 0.4x | 0.5x |
| Interest coverage | 9.5x | 6.7x | 7.7x | 7.1x | 5.0x | 5.3x | 7.9x | 10.6x | 7.7x | 6.9x |
| Current ratio | 1.2x | 0.9x | 1.1x | 0.8x | 0.7x | 0.8x | 0.7x | 0.5x | 0.4x | 0.5x |
| Quick ratio | 1.1x | 0.8x | 1.0x | 0.8x | 0.7x | 0.8x | 0.6x | 0.5x | 0.4x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.0% | 1.1% | 1.0% | 0.9% | 0.6% | 0.6% | 0.8% | 1.1% | 0.9% | 0.6% |
| Stock comp / revenue | 2.1% | 1.8% | 2.6% | 2.1% | 2.7% | 2.5% | 2.2% | 2.0% | 2.1% | 2.1% |
| Payouts / FCF | 13.1% | 12.0% | 12.3% | 13.5% | 14.3% | 11.9% | 37.8% | 14.8% | 13.8% | 34.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 6.0 | 7.0 | 5.0 | 4.0 | 6.0 | 5.0 | 5.0 | 5.0 | 5.0 |
| Altman Z'' | 2.4 | 2.7 | 3.1 | 2.9 | 2.1 | 2.5 | 3.3 | 3.5 | 3.2 | 3.1 |
| Accruals ratio | β2.5% | β1.8% | β3.3% | 1.8% | β2.7% | β3.6% | 15.0% | β2.4% | β2.8% | β3.1% |
Source: SEC EDGAR XBRL filings (CIK 0000882835). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.